Selective cell ablation in transgenic mice expressing E. coli nitroreductase

Gene Therapy

Volumn 4, Issue 2, 1997, Pages 101-110

  Clark, A J ^a   Iwobi, M ^b   Cui, W ^a   Crompton, M ^b   Harold, G ^a   Hobbs, S ^c   Kamalati, T ^b   Knox, R ^c   Neil, G ^a   Yull, F ^a   Gusterson, B ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Sect of Cell Biol and Exp Pathol   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

CB1954; Mammary gland; Nitroreductase; Selective ablation; Transgenic mice

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; BACTERIAL ENZYME; BETA LACTOGLOBULIN; NITROREDUCTASE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL KILLING; ESCHERICHIA COLI; MAMMARY GLAND; MOUSE; MYOEPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS MUSCULUS; OVIS;

EID: 8044241577     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300367     Document Type: Article

References (34)

1. Borrelli E et al. Transgenic mice with inducible dwarfism. Nature 1989; 339: 538-541.
2. Wallace H et al Specific ablation of thyroid follicle cells in adult transgenic mice. Endocrinology 1991; 129: 3217-3226.
3. Allen RG et al. Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrin 1995; 9: 1005-1016.
4. Canfield V, West B, Goldenring JR, Levenson R. Genetic ablation of parietal cells in transgenic mice: a new model for analysing cell lineage relationships in the gastric mucosa. Proc Natl Acad Sci USA 1996; 93: 2431-2435.
5. Wallace H et al. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes virus thymidine kinase occurs by p53 independent apoptosis. Oncogene 1996, 13: 55-61.
6. Al-Shawi R et al. The herpes simplex virus type 1 thymidine kinase is expressed in testes of transgenic mice under the control of a cryptic promoter. Mol Cell Biol 1991; 11: 4207-4216.
7. Salomon B et al. A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogues and does not cause sterility in transgenic mice Mol Cell Biol 1995; 15: 5322-5328.
8. Knox RJ, Friedlos F, Boland M. The bioactivahon of CB1954 and its use as a prodrug in antibody directed enzyme pro-drug therapy. Cancer Metast Rev 1993; 12: 195-212.
9. Bridgewater JA et al. Expression of nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur J Cancer 1995; 31A: 2362-2370.
10. Roberts JJ, Friedlos F. Quantitative estimation of cisplatin induced DNA interstrand cross-links and their repair in mammalian cells; relationships to toxicity. Pharm Ther 1987; 34: 215-246.
11. Simons JP, McClenaghan M, Clark AJ. Alteration of the quality of milk by expression of sheep β-lactoglobulin in transgenic mice. Nature 1987, 328: 530-532
12. Clark AJ et al. Rescuing transgene expression by cointegration. Bio/Technology 1992; 10: 1450-1454.
13. Traurig H. A radioautographic study of cell proliferation in the mammary gland of the pregnant mouse. Anat Rec 1967; 159: 239-248.
14. Harris S et al. Developmental regulation of the sheep β-lactoglo- bulin gene in the mammary gland of transgenic mice. Dev Genet 1991; 12: 299-307.
15. Archibald AL et al. Expression of biologically active human α1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA 1990; 87: 5178-5182.
16. Knox RJ, Friedlos F, Marchbank F, Roberts JJ. Bioactivation of CB 1954: reaction of the active 4-hydroxylamino derivative with thioesters to form the ultimate DNA-DNA interstrand crosslinking species. Biochem Pharmacol 1991; 42: 1691-1697.
17. Chen S et al Catalytic properties of NAD(P):quinone acceptor oxidoreductase: study involving mouse, rat, human and mouse-rat chimeric enzymes. Mol Pharmacol 1995; 44: 2297-2301.
18. Venitt S, Crofton-Sleigh C. The toxicity and mutagenicity of the anti-tumour drug 5-aziridine-2,4-dinitrobenzamide (CB1954) is greatly reduced in a nitroreductase-deficient strain of E. coli. Mutagencsis 1987; 2: 375-381.
19. Anlezark GM et al. The bioactivation of CB1954. I. Purification and properties of a nitroreductase enzyme for Escherichia coli - a potential enzyme for antibody directed enzyme prodrug therapy (ADEPT). Biochem Pharmacol 1992; 44: 2289-2295.
20. Knox RJ et al. The bioactivation of CB1954 a comparison of an Escherichia coli nitroreductase and Walker DT diaphorase. Biochem Pharmacol 1992; 44: 2297-2301.
21. Michael NP, Brehm JK, Anlezark GM, Minton NP. Physical characterisation of the Escherichia coli B gene encoding nitroreductase and its overexpression in Escherichia coli K12. FEMS Microbiol Lett 1994; 124: 195-202.
22. Yull F et al. Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active human factor IX in the mammary gland. Proc Natl Acad Sci USA 1995; 92: 10899-10903.
23. Sweetser DA et al. Transgenic mice containing intestinal fatty acid binding protein human growth hormone fusion gene exhibit correct regional and cell specific expression of the reporter gene in the intestine. Proc Natl Acad Sci USA 1988; 85: 9611-9615.
24. Bradl M, Larue L, Mintz B. Mosaic expression of a tyrosinase fusion gene in albino mice yields a heritable striped coat colour pattern in transgenic homozygotes. Proc Natl Acad Sci USA 1991; 88: 9643-9647.
25. Elliot JI, Festenstein R, Tolaini M, Kioussis D. Random activation of a transgene under the control of a hybrid CD2 locus control region/Ig enhancer regulatory element. EMBO J 1995; 14: 575-584.
26. Robertson G et al. Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci USA 1995; 92: 5371-5375.
27. Festenstein R et al. Locus control region function and heterochromatin induced position effect variegation. Science 1996; 271: 1123-1125.
28. Dobie KW et al. Variegated expression in mouse mammary gland is determined by the transgene integration locus. Proc Natl Acad Sci USA 1996; 93: 6659-6664.
29. Knox RJ, Friedlos F, Jarman M, Roberts JJ. 1988 A new cytotoxic agent DMA interstrand crosslinking agent 5′ (aziridin-l-yl)-4-hydroxylamino-2-dinitrobenzarnide (CB1954) by a nitroreductase enzyme in Walker carcinoma cells. Biochem Pharmacol 1988; 37: 4661-4669.
30. Workman P, White RAS, Talbot K. CB1954 revisited. I. Disposition kinetics and metabolism. Cancer Chemother Pharmacol 1986; 16: 1-8.
31. Workman P et al. CB1954 revisited II: toxicity and anti-tumour activity. Cancer Chemother Pharmacol 1986; 16: 9-14.
32. Kozak M. The scanning model for translation: an update. J Cell Biol 1989; 108: 229-241.
33. Ali S, Clark AJ. Characterisation of the gene encoding β-lactoglobulin: similarity to the genes for retinol binding protein and other secretory proteins. J Mol Biol 1988; 199: 415-426.
34. Whitelaw CBA et al. Targeting expression to the mammary gland; intronic sequences can enhance the efficiency of gene expression in transgenic mice. Transgenic Res 1991; 1: 3-13.